Multiple Dose ASM8 in Mild Asthmatics

Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma

NCT00822861 ·Status: COMPLETED ·Phase: PHASE2

A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

NCT01380236 ·Status: WITHDRAWN ·Phase: PHASE2

Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma

NCT01793298 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers

NCT00411814 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

NCT01370317 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

NCT06637371 ·Status: RECRUITING ·Phase: PHASE1

Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma

NCT00986037 ·Status: COMPLETED ·Phase: PHASE1

Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma

NCT02334553 ·Status: COMPLETED ·Phase: PHASE2

Titratable Dosing in Moderate to Severe Asthmatics

NCT00651768 ·Status: COMPLETED ·Phase: PHASE3

Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma

NCT00327808 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma

NCT01137565 ·Status: COMPLETED ·Phase: PHASE1

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg

NCT02091986 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma

NCT00507130 ·Status: COMPLETED ·Phase: PHASE2

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.

NCT01928368 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma

NCT00536913 ·Status: COMPLETED ·Phase: PHASE3

This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge

NCT00445510 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma

NCT00456677 ·Status: COMPLETED ·Phase: PHASE2

Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma

NCT00354666 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma

NCT00546143 ·Status: COMPLETED ·Phase: PHASE4

Study In Asthma Control

NCT00273026 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma

NCT00659659 ·Status: COMPLETED ·Phase: PHASE1

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

NCT00238784 ·Status: COMPLETED ·Phase: PHASE3

Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics

NCT01420003 ·Status: COMPLETED ·Phase: NA

A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children

NCT00569192 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

NCT00652392 ·Status: COMPLETED ·Phase: PHASE3